— Know what they know.
Not Investment Advice
Also trades as: 0R1F.L (LSE) · $vol 1M · BRM.DE (XETRA) · $vol 0M · BMY.SW (SIX) · $vol 0M

BMY NYSE

Bristol-Myers Squibb Company
1W: +4.9% 1M: +1.2% 3M: -1.9% YTD: +11.3% 1Y: +27.8% 3Y: -0.2% 5Y: +9.7%
$59.46
-0.09 (-0.15%)
 
Weekly Expected Move ±3.9%
$53 $55 $57 $59 $61
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 62 · $121.4B mcap · 2.04B float · 0.572% daily turnover · Short 56% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
47.7 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 17.2%  ·  5Y Avg: 7.2%
Cost Advantage
50
Intangibles
55
Switching Cost
35
Network Effect
28
Scale ★
73
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BMY shows a Weak competitive edge (47.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 17.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$65
Avg Target
$65
High
Based on 19 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 19Hold: 20Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$64.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-08 Cantor Fitzgerald $75 $54 -21 -8.8% $59.20
2026-03-06 UBS Michael Yee $65 $70 +5 +17.1% $59.78
2026-02-24 RBC Capital Trung Huynh Initiated $60 -2.6% $61.60
2026-02-23 Piper Sandler $66 $75 +9 +23.6% $60.66
2026-02-19 Barclays $41 $75 +34 +24.4% $60.30
2026-02-06 Morgan Stanley Terence Flynn $37 $40 +3 -35.3% $61.86
2026-02-06 Guggenheim $62 $72 +10 +21.0% $59.52
2026-02-06 Wells Fargo Mohit Bansal $70 $60 -10 +0.8% $59.52
2026-01-28 Piper Sandler $65 $66 +1 +18.8% $55.56
2026-01-13 Leerink Partners David Risinger $66 $60 -6 +6.4% $56.39
2026-01-09 Scotiabank Louise Chen $53 $60 +7 +7.4% $55.87
2026-01-07 UBS $43 $65 +22 +15.2% $56.41
2025-12-12 Morgan Stanley $64 $37 -27 -29.7% $52.63
2025-12-12 Guggenheim $80 $62 -18 +21.1% $51.20
2025-12-10 HSBC Initiated $53 +4.6% $50.68
2025-12-04 Scotiabank Louis Chen Initiated $53 +4.0% $50.96
2025-12-03 Truist Financial Srikripa Devarakonda $84 $65 -19 +27.5% $50.98
2025-08-05 Daiwa Narumi Nakagiri Initiated $42 -8.4% $45.85
2025-07-21 Truist Financial David Macdonald Initiated $84 +78.3% $47.12
2025-04-23 Jefferies Akash Tewari Initiated $68 +40.1% $48.52
2025-04-22 Piper Sandler David Amsellem Initiated $65 +30.5% $49.82
2024-11-12 BMO Capital Evan Seigerman $57 $61 +4 +8.5% $56.23
2024-11-01 BMO Capital Evan David Seigerman $48 $57 +9 +4.9% $54.32
2024-09-23 BMO Capital Evan David Seigerman $60 $48 -12 -3.1% $49.56
2024-07-29 Goldman Sachs Chris Shibutani Initiated $57 +12.8% $50.55
2024-07-29 Barclays Carter Gould $68 $41 -27 -18.7% $50.45
2024-07-12 UBS Trung Huynh Initiated $43 +5.7% $40.68
2024-05-16 Cowen & Co. Steve Scala Initiated $67 +51.9% $44.11
2024-01-30 Deutsche Bank James Shin Initiated $55 +10.3% $49.87
2023-11-27 BMO Capital Evan Seigerman $92 $60 -32 +20.6% $49.76
2023-10-12 Leerink Partners David Risinger Initiated $66 +17.3% $56.24
2023-09-06 Cantor Fitzgerald Louise Chen Initiated $75 +25.7% $59.67
2022-05-18 Wells Fargo Mohit Bansal Initiated $70 -10.5% $78.22
2022-05-02 BMO Capital $87 $92 +5 +21.6% $75.66
2022-05-02 Barclays $66 $68 +2 -9.7% $75.27
2022-05-02 Guggenheim Seamus Fernandez $82 $80 -2 +6.3% $75.27
2022-05-01 BMO Capital Evan Seigerman $81 $87 +6 +15.9% $75.08
2022-04-10 Morgan Stanley Terence Flynn $66 $64 -2 -16.3% $76.50
2022-04-03 BMO Capital Evan Seigerman $74 $81 +7 +9.8% $73.79
2022-03-27 Morgan Stanley Matthew Harrison Initiated $66 -9.7% $73.11
2022-03-16 BMO Capital Evan David Seigerman Initiated $74 +4.9% $70.52
2021-10-27 Barclays Carter Gould Initiated $66 +17.4% $56.22
2021-10-24 Citigroup Andrew Baum Initiated $75 +31.8% $56.89
2021-09-19 Guggenheim Seamus Fernandez Initiated $82 +38.9% $59.05
2021-09-06 Societe Generale Justin Smith Initiated $85 +33.6% $63.63

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BMY receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-14 A- B+
2026-04-30 B+ A-
2026-04-30 A- B+
2026-04-01 B+ A-
2026-03-12 A- B+
2026-03-04 B+ A-
2026-02-19 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

65 Grade A
Profitability
84
Balance Sheet
45
Earnings Quality
62
Growth
62
Value
52
Momentum
86
Safety
50
Cash Flow
67
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BMY scores highest in Momentum (86/100) and lowest in Balance Sheet (45/100). An overall grade of A places BMY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.29
Grey Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.84
Unlikely Manipulator
Ohlson O-Score
-7.44
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB
Score: 57.1/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.83x
Accruals: -6.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BMY scores 2.29, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BMY scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BMY's score of -2.84 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BMY's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BMY receives an estimated rating of BBB (score: 57.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BMY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
16.70x
PEG
0.51x
P/S
2.50x
P/B
6.05x
P/FCF
10.30x
P/OCF
9.22x
EV/EBITDA
11.55x
EV/Revenue
3.28x
EV/EBIT
15.17x
EV/FCF
13.36x
Earnings Yield
5.93%
FCF Yield
9.71%
Shareholder Yield
4.21%
Graham Number
$26.91
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 16.7x earnings, BMY trades at a reasonable valuation. An earnings yield of 5.9% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $26.91 per share, 121% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.758
NI / EBT
×
Interest Burden
0.915
EBT / EBIT
×
EBIT Margin
0.216
EBIT / Rev
×
Asset Turnover
0.531
Rev / Assets
×
Equity Multiplier
5.247
Assets / Equity
=
ROE
41.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BMY's ROE of 41.8% is driven by financial leverage (equity multiplier: 5.25x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.95%
Fair P/E
10.41x
Intrinsic Value
$37.06
Price/Value
1.62x
Margin of Safety
-61.99%
Premium
61.99%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BMY's realized 1.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $37.06, BMY appears undervalued with a -62% margin of safety. The adjusted fair P/E of 10.4x compares to the current market P/E of 16.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$59.47
Median 1Y
$61.67
5th Pctile
$41.69
95th Pctile
$91.25
Ann. Volatility
24.3%
Analyst Target
$64.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Christopher S. Boerner,
Ph.D. Board Chair and Chief Executive Officer
$1,586,346 $16,061,399 $21,879,919
Samit Hirawat ,
M.D. Former EVP, Chief Medical Officer, Head of Development
$964,904 $5,815,320 $10,334,233
Cristian Massacesi ,
M.D. EVP, Chief Medical Officer, Head of Development
$388,462 $7,853,994 $10,072,950
Adam Lenkowsky EVP,
Chief Commercialization Officer
$1,131,731 $6,136,800 $9,340,352
David V. Elkins
EVP and Chief Financial Officer
$1,140,442 $5,981,513 $9,177,590
Greg Meyers EVP,
Chief Digital and Technology Officer
$1,072,692 $4,209,168 $7,181,173

CEO Pay Ratio

98:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $21,879,919
Avg Employee Cost (SGA/emp): $222,892
Employees: 32,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
32,500
-4.7% YoY
Revenue / Employee
$1,482,892
Rev: $48,194,000,000
Profit / Employee
$217,015
NI: $7,053,000,000
SGA / Employee
$222,892
Avg labor cost proxy
R&D / Employee
$295,754
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -11.4% -12.1% 19.0% 16.9% 17.9% 18.1% 18.9% 21.8% 23.8% 24.7% 26.5% -20.3% -21.6% -24.0% -39.1% 23.7% 22.1% 26.4% 40.5% 41.8% 41.80%
ROA -4.1% -4.4% 6.1% 5.5% 5.8% 5.9% 6.1% 7.1% 7.7% 8.0% 8.4% -6.4% -6.8% -7.6% -9.5% 5.8% 5.4% 6.4% 7.7% 8.0% 7.97%
ROIC 6.3% 6.7% 10.4% 11.1% 12.6% 13.3% 12.3% 12.1% 12.2% 12.6% 13.7% 10.2% 11.0% 11.3% 12.5% 17.2% 16.9% 18.3% 17.5% 17.2% 17.17%
ROCE -2.7% -2.9% 10.8% 9.8% 10.2% 10.3% 11.9% 13.3% 13.2% 13.0% 13.2% -6.3% -6.7% -7.0% -9.3% 11.8% 12.5% 14.5% 16.0% 15.7% 15.75%
Gross Margin 57.3% 58.2% 60.0% 58.0% 57.1% 57.5% 56.9% 57.5% 54.6% 56.7% 56.6% 55.5% 55.7% 55.6% 60.2% 65.5% 65.8% 71.9% 67.2% 70.2% 70.22%
Operating Margin 13.3% 14.9% 18.6% 23.3% 22.6% 19.9% 15.0% 21.6% 17.3% 19.2% 17.0% 12.9% 21.2% 19.2% 20.5% 31.4% 33.6% 29.8% 11.4% 28.5% 28.47%
Net Margin 9.0% 13.3% 19.8% 11.0% 12.0% 14.3% 17.7% 20.0% 18.5% 17.6% 15.4% -1.0% 13.8% 10.2% 0.6% 21.9% 10.7% 18.0% 8.7% 23.3% 23.31%
EBITDA Margin 39.3% 44.8% 39.7% 39.5% 40.8% 45.4% 41.0% 48.4% 40.7% 44.2% 38.8% -72.1% 36.1% 40.1% 20.7% 40.0% 26.8% 37.5% 17.5% 32.3% 32.27%
FCF Margin 27.0% 32.7% 32.8% 32.2% 30.3% 27.2% 25.9% 24.2% 23.7% 26.0% 28.1% 27.5% 27.8% 29.1% 28.9% 27.5% 30.6% 31.9% 26.7% 24.6% 24.56%
OCF Margin 28.9% 34.8% 34.9% 34.5% 32.7% 29.6% 28.3% 26.7% 26.2% 28.7% 30.8% 30.1% 30.5% 31.6% 31.4% 30.0% 33.3% 34.6% 29.4% 27.4% 27.45%
ROE 3Y Avg snapshot only 17.22%
ROE 5Y Avg snapshot only 18.52%
ROA 3Y Avg snapshot only 2.49%
ROIC 3Y Avg snapshot only 5.93%
ROIC Economic snapshot only 14.59%
Cash ROA snapshot only 14.78%
Cash ROIC snapshot only 24.22%
CROIC snapshot only 21.67%
NOPAT Margin snapshot only 19.45%
Pretax Margin snapshot only 19.79%
R&D / Revenue snapshot only 20.68%
SGA / Revenue snapshot only 15.01%
SBC / Revenue snapshot only 1.14%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -24.77 -20.85 16.80 21.82 21.73 19.87 21.15 17.68 15.02 12.98 11.79 -16.37 -11.95 -13.64 -12.27 22.08 18.19 15.01 15.43 16.86 16.702
P/S Ratio 2.83 2.48 2.53 2.90 3.05 2.84 2.90 2.82 2.65 2.39 2.10 2.21 1.68 2.09 2.27 2.51 1.93 1.89 2.26 2.53 2.504
P/B Ratio 3.33 2.98 3.27 3.79 4.00 3.69 4.31 4.16 3.85 3.46 3.21 3.42 2.66 3.36 6.72 7.32 5.62 5.55 5.89 6.64 6.055
P/FCF 10.48 7.57 7.71 9.01 10.07 10.43 11.20 11.66 11.16 9.20 7.48 8.04 6.04 7.17 7.87 9.14 6.30 5.93 8.47 10.30 10.302
P/OCF 9.81 7.12 7.25 8.42 9.34 9.60 10.24 10.57 10.09 8.33 6.82 7.33 5.52 6.60 7.23 8.36 5.78 5.46 7.69 9.22 9.219
EV/EBITDA 20.14 18.60 7.25 8.60 8.86 8.34 8.60 7.99 7.62 7.10 6.39 24.40 20.85 25.28 47.38 9.87 8.76 8.79 9.99 11.55 11.552
EV/Revenue 3.63 3.25 3.14 3.51 3.65 3.45 3.58 3.50 3.34 3.09 2.75 2.85 2.31 2.70 3.11 3.36 2.77 2.73 3.01 3.28 3.282
EV/EBIT -59.05 -51.99 15.46 19.24 19.23 17.95 18.47 16.09 15.32 14.26 12.91 -28.45 -21.93 -25.07 -23.34 19.70 15.42 13.12 13.60 15.17 15.169
EV/FCF 13.42 9.94 9.57 10.88 12.05 12.66 13.83 14.50 14.09 11.89 9.78 10.38 8.29 9.29 10.77 12.23 9.07 8.56 11.31 13.36 13.364
Earnings Yield -4.0% -4.8% 6.0% 4.6% 4.6% 5.0% 4.7% 5.7% 6.7% 7.7% 8.5% -6.1% -8.4% -7.3% -8.2% 4.5% 5.5% 6.7% 6.5% 5.9% 5.93%
FCF Yield 9.5% 13.2% 13.0% 11.1% 9.9% 9.6% 8.9% 8.6% 9.0% 10.9% 13.4% 12.4% 16.6% 13.9% 12.7% 10.9% 15.9% 16.9% 11.8% 9.7% 9.71%
PEG Ratio snapshot only 0.509
EV/OCF snapshot only 11.960
EV/Gross Profit snapshot only 4.775
Acquirers Multiple snapshot only 12.786
Shareholder Yield snapshot only 4.21%
Graham Number snapshot only $26.91
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.58 1.58 1.52 1.52 1.52 1.52 1.25 1.25 1.25 1.25 1.43 1.43 1.43 1.43 1.25 1.25 1.25 1.25 1.26 1.26 1.255
Quick Ratio 1.47 1.47 1.43 1.43 1.43 1.43 1.14 1.14 1.14 1.14 1.31 1.31 1.31 1.31 1.15 1.15 1.15 1.15 1.14 1.14 1.140
Debt/Equity 1.37 1.37 1.27 1.27 1.27 1.27 1.31 1.31 1.31 1.31 1.41 1.41 1.41 1.41 3.13 3.13 3.13 3.13 2.55 2.55 2.552
Net Debt/Equity 0.93 0.93 0.79 0.79 0.79 0.79 1.01 1.01 1.01 1.01 0.99 0.99 0.99 0.99 2.47 2.47 2.47 2.47 1.97 1.97 1.974
Debt/Assets 0.44 0.44 0.42 0.42 0.42 0.42 0.42 0.42 0.42 0.42 0.44 0.44 0.44 0.44 0.55 0.55 0.55 0.55 0.52 0.52 0.524
Debt/EBITDA 6.46 6.50 2.27 2.38 2.35 2.36 2.12 2.02 2.05 2.08 2.14 7.79 8.05 8.18 16.16 3.16 3.39 3.44 3.24 3.42 3.422
Net Debt/EBITDA 4.40 4.43 1.41 1.48 1.46 1.47 1.64 1.56 1.59 1.61 1.51 5.49 5.67 5.76 12.73 2.49 2.67 2.71 2.51 2.65 2.647
Interest Coverage -1.97 -2.08 7.07 6.55 6.94 7.12 7.26 8.37 8.48 8.52 8.22 -3.50 -3.17 -2.89 -3.30 4.03 4.33 5.11 7.08 10.33 10.326
Equity Multiplier 3.13 3.13 3.04 3.04 3.04 3.04 3.12 3.12 3.12 3.12 3.23 3.23 3.23 3.23 5.67 5.67 5.67 5.67 4.87 4.87 4.874
Cash Ratio snapshot only 0.456
Debt Service Coverage snapshot only 13.559
Cash to Debt snapshot only 0.226
FCF to Debt snapshot only 0.253
Defensive Interval snapshot only 440.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.36 0.37 0.41 0.41 0.41 0.41 0.45 0.44 0.44 0.44 0.47 0.47 0.48 0.49 0.51 0.51 0.51 0.51 0.53 0.53 0.531
Inventory Turnover 6.21 6.18 9.41 9.37 9.42 9.38 8.87 8.84 8.84 8.83 7.86 8.04 8.16 8.37 8.00 7.46 6.99 6.29 5.94 5.78 5.775
Receivables Turnover 6.48 6.64 6.10 6.18 6.20 6.15 5.72 5.68 5.60 5.57 5.28 5.35 5.46 5.57 5.40 5.32 5.33 5.37 5.18 5.21 5.212
Payables Turnover 7.67 7.62 6.93 6.90 6.93 6.90 6.57 6.55 6.55 6.54 6.24 6.38 6.48 6.65 6.08 5.67 5.32 4.78 4.34 4.22 4.222
DSO 56 55 60 59 59 59 64 64 65 66 69 68 67 66 68 69 68 68 70 70 70.0 days
DIO 59 59 39 39 39 39 41 41 41 41 46 45 45 44 46 49 52 58 61 63 63.2 days
DPO 48 48 53 53 53 53 56 56 56 56 59 57 56 55 60 64 69 76 84 86 86.4 days
Cash Conversion Cycle 67 66 46 45 45 45 49 50 51 51 57 56 55 54 53 53 52 50 48 47 46.8 days
Fixed Asset Turnover snapshot only 5.313
Operating Cycle snapshot only 133.2 days
Cash Velocity snapshot only 4.542
Capital Intensity snapshot only 1.857
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 27.3% 15.4% 9.1% 9.7% 6.2% 2.8% -0.5% -2.4% -4.2% -3.9% -2.5% -0.7% 2.9% 5.6% 7.3% 4.6% 2.6% 1.3% -0.2% 1.8% 1.78%
Net Income -8.0% -121.8% 1.8% 2.0% 2.3% 2.2% -9.5% 17.0% 20.3% 24.1% 26.8% -1.8% -1.8% -1.9% -2.1% 1.9% 1.8% 1.8% 1.8% 34.2% 34.25%
EPS -8.1% -124.4% 1.8% 2.1% 2.4% 2.3% -5.5% 19.8% 23.0% 29.1% 32.5% -1.9% -1.9% -1.9% -2.1% 1.9% 1.8% 1.8% 1.8% 33.8% 33.82%
FCF -2.2% 23.9% 11.9% 12.0% 19.0% -14.5% -21.6% -26.8% -24.9% -8.1% 5.9% 12.9% 20.8% 18.1% 10.2% 4.6% 12.6% 10.9% -7.9% -9.0% -9.00%
EBITDA -21.5% -42.0% 3.1% 1.4% 1.4% 1.4% -4.5% 4.9% 2.1% 1.4% 0.8% -73.5% -74.0% -74.1% -83.6% 2.0% 1.9% 1.9% 3.6% -15.0% -14.98%
Op. Income 33.9% 58.1% 94.8% 57.4% 60.0% 58.6% 21.0% 10.3% -11.0% -16.7% -9.5% -17.1% -2.0% 1.8% 5.8% 45.0% 52.4% 65.2% 42.0% 13.9% 13.93%
OCF Growth snapshot only -7.02%
Asset Growth snapshot only -2.77%
Equity Growth snapshot only 13.09%
Debt Growth snapshot only -7.93%
Shares Change snapshot only 0.32%
Dividend Growth snapshot only 3.28%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 27.1% 27.3% 27.2% 26.3% 25.5% 24.6% 20.9% 13.9% 9.0% 4.5% 1.9% 2.1% 1.6% 1.4% 1.4% 0.5% 0.4% 0.9% 1.4% 1.9% 1.88%
Revenue 5Y 20.3% 19.7% 19.0% 18.7% 18.4% 17.8% 17.3% 16.9% 15.9% 15.3% 14.8% 14.4% 14.3% 14.4% 13.1% 9.0% 6.5% 4.0% 2.5% 2.5% 2.52%
EPS 3Y 1.6% -2.8% -6.7% -3.5% 18.4% 1.0% -2.7% -7.0% -1.6% 5.1% 1.0% 0.95%
EPS 5Y 3.5% -0.0% 2.1% 3.9% 37.2% 43.9% 75.1% 35.6% 5.6% 44.5%
Net Income 3Y 12.4% 6.7% 2.2% 5.7% 22.5% 97.2% -4.6% -8.6% -3.3% 3.7% -0.2% -0.16%
Net Income 5Y 9.4% 5.3% 7.6% 9.6% 44.4% 51.4% 84.2% 42.1% 10.3% 41.5%
EBITDA 3Y 16.5% 9.8% 43.6% 39.8% 32.4% 35.8% 37.6% 37.6% 24.8% 12.6% 57.8% -12.5% -13.6% -13.9% -46.0% -5.4% -8.1% -8.3% -8.9% -11.8% -11.85%
EBITDA 5Y 12.9% 10.1% 25.5% 22.7% 23.7% 24.6% 25.7% 27.8% 31.5% 26.7% 23.3% -5.4% -9.2% -8.1% -15.6% 16.0% 8.2% 1.7% 24.2% 11.6% 11.64%
Gross Profit 3Y 17.5% 18.5% 18.6% 18.4% 17.8% 17.0% 15.7% 13.6% 11.3% 8.5% 5.3% 3.5% 2.0% 0.9% 0.8% 0.9% 2.3% 5.2% 7.2% 8.3% 8.29%
Gross Profit 5Y 13.1% 13.1% 13.4% 13.3% 13.3% 12.9% 12.2% 12.1% 11.0% 10.3% 9.6% 9.0% 9.2% 9.3% 9.9% 9.5% 9.7% 9.7% 8.5% 7.8% 7.76%
Op. Income 3Y 13.1% 10.1% 13.9% 13.7% 9.8% 11.1% 14.0% 18.6% 24.0% 27.8% 28.7% 12.9% 11.8% 10.4% 5.0% 9.9% 10.0% 11.9% 10.8% 11.1% 11.06%
Op. Income 5Y 16.4% 12.5% 11.0% 10.1% 11.4% 13.8% 12.4% 12.7% 15.6% 12.0% 10.1% 6.1% 3.0% 3.1% 7.2% 14.9% 23.3% 28.5% 26.2% 18.9% 18.92%
FCF 3Y 42.9% 58.9% 45.1% 42.4% 31.6% 18.8% 18.2% 4.2% -4.4% -0.9% -2.4% -2.5% 2.6% -2.5% -2.9% -4.7% 0.7% 6.3% 2.4% 2.4% 2.43%
FCF 5Y 1.1% 68.5% 52.8% 39.5% 28.8% 23.6% 23.1% 19.3% 21.1% 25.8% 20.5% 19.0% 15.6% 12.7% 14.0% 6.0% 3.5% 5.0% -1.2% -2.5% -2.50%
OCF 3Y 36.3% 50.6% 39.7% 38.1% 28.9% 17.8% 17.4% 4.8% -3.1% 0.5% -1.2% -1.3% 3.4% -1.8% -2.1% -4.0% 1.1% 6.4% 2.7% 2.9% 2.87%
OCF 5Y 57.0% 48.0% 39.7% 31.4% 23.9% 19.9% 19.9% 16.9% 18.5% 22.8% 18.5% 17.4% 14.5% 12.1% 13.5% 6.2% 4.1% 5.5% -0.3% -1.4% -1.37%
Assets 3Y 52.3% 52.3% 46.2% 46.2% 46.2% 46.2% -9.3% -9.3% -9.3% -9.3% -7.0% -7.0% -7.0% -7.0% -5.4% -5.4% -5.4% -5.4% -2.4% -2.4% -2.39%
Assets 5Y 30.1% 30.1% 26.5% 26.5% 26.5% 26.5% 23.6% 23.6% 23.6% 23.6% 22.2% 22.2% 22.2% 22.2% -6.6% -6.6% -6.6% -6.6% -5.3% -5.3% -5.34%
Equity 3Y 47.7% 47.7% 36.8% 36.8% 36.8% 36.8% -15.6% -15.6% -15.6% -15.6% -8.0% -8.0% -8.0% -8.0% -23.1% -23.1% -23.1% -23.1% -15.9% -15.9% -15.90%
Book Value 3Y 32.8% 32.9% 23.6% 24.7% 25.0% 24.9% -18.4% -13.7% -13.5% -12.6% -4.8% -4.5% -4.8% -4.9% -20.9% -21.6% -21.7% -21.8% -14.8% -15.0% -14.96%
Dividend 3Y -3.0% -5.4% -7.3% -6.7% -6.7% -6.8% -1.6% 3.5% 3.7% 4.6% 4.3% 4.7% 4.2% 3.9% 3.7% 3.1% 3.0% 3.1% 2.6% 2.2% 2.21%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.85 0.83 0.83 0.90 0.92 0.89 0.87 0.91 0.87 0.80 0.72 0.72 0.70 0.70 0.70 0.68 0.70 0.79 0.84 0.94 0.943
Earnings Stability 0.42 0.50 0.03 0.05 0.02 0.03 0.03 0.09 0.13 0.11 0.12 0.05 0.05 0.05 0.01 0.04 0.05 0.05 0.05 0.17 0.173
Margin Stability 0.85 0.84 0.85 0.86 0.85 0.85 0.87 0.89 0.89 0.88 0.87 0.89 0.89 0.90 0.94 0.98 0.94 0.90 0.90 0.90 0.901
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.89 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness 0.90 0.84 0.82 0.79 0.76 0.71 0.708
ROE Trend -0.35 -0.34 0.28 0.25 0.26 0.26 0.23 0.23 0.23 0.25 0.07 -0.41 -0.44 -0.47 -0.79 0.32 0.29 0.36 0.52 0.33 0.332
Gross Margin Trend -0.06 -0.04 -0.01 0.03 0.04 0.05 0.03 0.01 -0.00 -0.01 -0.01 -0.02 -0.01 -0.01 -0.00 0.03 0.05 0.10 0.11 0.11 0.112
FCF Margin Trend -0.04 0.02 0.03 0.01 -0.01 -0.04 -0.07 -0.08 -0.05 -0.04 -0.01 -0.01 0.01 0.02 0.02 0.02 0.05 0.04 -0.02 -0.03 -0.029
Sustainable Growth Rate 7.0% 4.8% 5.7% 5.7% 5.1% 8.0% 9.8% 10.6% 10.8% 2.2% 0.4% 4.5% 11.5% 12.7% 12.67%
Internal Growth Rate 2.3% 1.6% 1.9% 1.9% 1.7% 2.7% 3.3% 3.6% 3.5% 0.5% 0.1% 1.1% 2.2% 2.5% 2.47%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -2.52 -2.93 2.32 2.59 2.33 2.07 2.07 1.67 1.49 1.56 1.73 -2.23 -2.17 -2.07 -1.70 2.64 3.15 2.75 2.01 1.83 1.829
FCF/OCF 0.94 0.94 0.94 0.93 0.93 0.92 0.91 0.91 0.90 0.91 0.91 0.91 0.91 0.92 0.92 0.91 0.92 0.92 0.91 0.89 0.895
FCF/Net Income snapshot only 1.637
OCF/EBITDA snapshot only 0.966
CapEx/Revenue 1.8% 2.1% 2.1% 2.2% 2.4% 2.3% 2.4% 2.5% 2.5% 2.7% 2.7% 2.7% 2.6% 2.5% 2.6% 2.6% 2.8% 2.7% 2.7% 2.9% 2.88%
CapEx/Depreciation snapshot only 0.426
Accruals Ratio -0.14 -0.17 -0.08 -0.09 -0.08 -0.06 -0.07 -0.05 -0.04 -0.04 -0.06 -0.21 -0.22 -0.23 -0.26 -0.09 -0.12 -0.11 -0.08 -0.07 -0.066
Sloan Accruals snapshot only -0.036
Cash Flow Adequacy snapshot only 2.057
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 3.4% 3.8% 3.7% 3.3% 3.1% 3.5% 3.5% 3.6% 3.9% 4.4% 5.0% 4.7% 6.1% 4.9% 4.4% 4.1% 5.4% 5.5% 4.6% 4.1% 4.20%
Dividend/Share $1.88 $1.93 $1.98 $2.07 $2.11 $2.14 $2.18 $2.20 $2.23 $2.29 $2.33 $2.35 $2.36 $2.37 $2.39 $2.41 $2.43 $2.45 $2.47 $2.48 $2.50
Payout Ratio 62.9% 71.6% 68.4% 68.7% 73.2% 63.5% 58.9% 57.1% 59.1% 90.6% 98.1% 82.8% 71.5% 69.7% 69.69%
FCF Payout Ratio 35.4% 29.0% 28.9% 29.5% 31.7% 36.1% 38.8% 41.9% 43.8% 40.5% 37.5% 38.1% 36.9% 34.8% 34.9% 37.5% 34.0% 32.7% 39.3% 42.6% 42.58%
Total Payout Ratio 1.5% 2.2% 1.9% 1.9% 2.0% 1.1% 1.1% 1.5% 1.2% 90.6% 98.1% 82.8% 71.5% 71.0% 71.04%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.29 0.20 0.12 0.11 0.10 0.10 0.09 0.07 0.08 0.07 0.07 0.07 0.08 0.06 0.07 0.07 0.09 0.10 0.08 0.07 0.074
Buyback Yield 3.6% 4.4% 5.4% 7.0% 5.8% 6.3% 6.0% 2.5% 3.5% 7.0% 5.5% 4.9% 5.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.08%
Net Buyback Yield 3.6% 4.4% 5.4% 7.0% 5.8% 6.3% 6.0% 2.5% 3.5% 7.0% 5.5% 4.9% 5.1% 0.0% 0.0% 0.0% 0.0% -0.0% -0.0% 0.1% 0.05%
Total Shareholder Return 6.9% 8.3% 9.1% 10.3% 8.9% 9.7% 9.4% 6.1% 7.4% 11.4% 10.5% 9.6% 11.2% 4.9% 4.4% 4.1% 5.4% 5.5% 4.6% 4.2% 4.18%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.24 1.28 0.86 0.86 0.86 0.87 0.82 0.83 0.92 0.96 0.95 1.05 1.02 1.05 1.07 0.89 0.77 0.75 0.76 0.76 0.758
Interest Burden (EBT/EBIT) 1.51 1.48 0.86 0.85 0.86 0.86 0.86 0.88 0.88 0.88 0.88 1.28 1.31 1.35 1.30 0.75 0.77 0.80 0.87 0.91 0.915
EBIT Margin -0.06 -0.06 0.20 0.18 0.19 0.19 0.19 0.22 0.22 0.22 0.21 -0.10 -0.11 -0.11 -0.13 0.17 0.18 0.21 0.22 0.22 0.216
Asset Turnover 0.36 0.37 0.41 0.41 0.41 0.41 0.45 0.44 0.44 0.44 0.47 0.47 0.48 0.49 0.51 0.51 0.51 0.51 0.53 0.53 0.531
Equity Multiplier 2.78 2.78 3.09 3.09 3.09 3.09 3.08 3.08 3.08 3.08 3.17 3.17 3.17 3.17 4.10 4.10 4.10 4.10 5.25 5.25 5.247
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-2.26 $-2.41 $3.15 $2.89 $3.08 $3.11 $2.98 $3.46 $3.79 $4.01 $3.95 $-3.04 $-3.22 $-3.57 $-4.39 $2.66 $2.48 $2.96 $3.46 $3.56 $3.56
Book Value/Share $16.79 $16.86 $16.20 $16.61 $16.73 $16.73 $14.62 $14.70 $14.78 $15.05 $14.48 $14.55 $14.50 $14.49 $8.02 $8.02 $8.02 $8.02 $9.05 $9.04 $9.84
Tangible Book/Share $-16.06 $-16.13 $-12.32 $-12.63 $-12.72 $-12.72 $-12.45 $-12.51 $-12.58 $-12.81 $-9.46 $-9.50 $-9.47 $-9.47 $-14.25 $-14.25 $-14.24 $-14.24 $-10.97 $-10.95 $-10.95
Revenue/Share $19.71 $20.27 $20.90 $21.70 $21.94 $21.76 $21.73 $21.70 $21.50 $21.77 $22.14 $22.51 $22.92 $23.36 $23.71 $23.39 $23.41 $23.57 $23.61 $23.72 $23.72
FCF/Share $5.33 $6.64 $6.87 $7.00 $6.65 $5.92 $5.63 $5.24 $5.10 $5.66 $6.22 $6.18 $6.38 $6.80 $6.84 $6.42 $7.15 $7.51 $6.29 $5.83 $5.83
OCF/Share $5.69 $7.05 $7.30 $7.48 $7.16 $6.43 $6.15 $5.79 $5.64 $6.26 $6.82 $6.78 $6.98 $7.39 $7.46 $7.03 $7.80 $8.16 $6.94 $6.51 $6.51
Cash/Share $7.30 $7.33 $7.76 $7.96 $8.01 $8.02 $4.36 $4.38 $4.40 $4.48 $6.04 $6.07 $6.05 $6.05 $5.33 $5.33 $5.33 $5.33 $5.23 $5.22 $5.13
EBITDA/Share $3.55 $3.55 $9.07 $8.86 $9.04 $8.99 $9.05 $9.52 $9.43 $9.49 $9.53 $2.63 $2.54 $2.50 $1.56 $7.95 $7.40 $7.31 $7.13 $6.74 $6.74
Debt/Share $22.95 $23.04 $20.55 $21.07 $21.22 $21.23 $19.17 $19.27 $19.37 $19.73 $20.40 $20.50 $20.44 $20.42 $25.14 $25.14 $25.12 $25.12 $23.10 $23.07 $23.07
Net Debt/Share $15.64 $15.70 $12.79 $13.11 $13.20 $13.21 $14.81 $14.89 $14.97 $15.24 $14.36 $14.43 $14.38 $14.37 $19.80 $19.80 $19.79 $19.79 $17.87 $17.84 $17.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.294
Altman Z-Prime snapshot only 3.631
Piotroski F-Score 5 5 7 7 6 6 5 6 6 6 6 5 6 5 4 6 6 6 7 7 7
Beneish M-Score -2.99 -3.09 -2.77 -2.84 -2.73 -2.67 -2.70 -2.64 -2.59 -2.64 -2.70 -3.45 -3.45 -3.51 -3.75 -3.01 -3.14 -3.17 -2.95 -2.84 -2.842
Ohlson O-Score snapshot only -7.438
Net-Net WC snapshot only $-20.62
EVA snapshot only $3938188986.14
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB
Credit Score 28.52 29.67 59.38 56.73 57.76 60.63 57.69 58.75 58.00 58.47 61.75 31.72 30.77 30.00 24.97 47.40 46.83 48.67 53.58 57.08 57.079
Credit Grade snapshot only 9
Credit Trend snapshot only 9.678
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 38
Sector Credit Rank snapshot only 52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms